This Study Will Compare the Efficacy and Safety of SCT510A Administered by Intravitreal Injection (IVT) With Ranibizumab in Patients With wAMD
Clinical trial NCT05480293 · UNKNOWN
Trial details
- NCT number
- NCT05480293
- Sponsor
- Sinocelltech Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-14
- Primary completion
- 2025-07-31
- Enrollment
- 446
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.